Marsh & McLennan (MMC) Tops Q3 EPS by 4c

Marsh & McLennan (NYSE: MMC) reported Q3 EPS of $0.56, $0.04 better than the analyst estimate of $0.52. Revenue for the quarter came in at $3.1 billion versus the consensus estimate of $3.09 billion.

Marsh & McLennan Companies President and CEO Dan Glaser said: "The Company delivered its thirteenth consecutive quarter of double-digit growth in adjusted earnings per share. This strong performance reflects revenue growth of 7% and underlying revenue growth of 5%, with all operating companies contributing. Adjusted operating income grew 11%, and the adjusted margin expanded 50 basis points.

For the nine months of 2014, results were excellent: revenue growth of 6% and underlying revenue growth of 5%; an 11% increase in adjusted operating income; margin improvement of 80 basis points; and 13% growth in adjusted EPS.”

For earnings history and earnings-related data on Marsh & McLennan (MMC) click here.

You May Also Be Interested In

• Bristol-Myers Squibb (BMY) tops Q1 earnings, revenue estimates; FY guidance updated
• Ultralife Corp. (ULBI) Tops Q1 EPS by 12c
• TechnipFMC (FTI) Tops Q1 EPS by 6c, provides guidance